PharmaRadar360

PharmaRadar360

🇺🇸·15h agoRegulatory

Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Anti-Tumor Necrosis Factor Alpha Monoclonal Antibody Test System for Inflammatory Bowel Disease

The Food and Drug Administration (FDA) is classifying the anti-tumor necrosis factor alpha monoclona...

Publisher

F
Federal Register

USA

This page provides a limited summary, publisher metadata, and related coverage to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
Federal Register
Region
USA
Scope
Regulatory
Published
September 10, 2026
Language
EN

Publisher context, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Summary excerpt

The Food and Drug Administration (FDA) is classifying the anti-tumor necrosis factor alpha monoclona...

Source route

Continue on federalregister.gov

Leave the platform to read the original full article on the publisher site.

Source: Federal Register

Scope: Regulatory

Open original article
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Anti-Tumor Necrosis Factor Alpha Monoclonal Antibody Test System for Inflammatory Bowel Disease | PharmaRadar360